The biopharmaceutical study of doxycycline interaction with mineral waters and soft drinks in vitro
DOI:
https://doi.org/10.24959/cphj.17.1434Keywords:
doxycycline capsules, dissolution test, metal cations, complexes, interaction with mineral waterAbstract
When taking the antibiotics of the tetracycline group together with food and drinks the components may decrease bioavailability, the effectiveness of the drug and change the kinetics of its release. A bright example is the interaction of doxycycline with antacid drugs, food products such as milk, cheese and others, containing alkaline earth metal cations. However, the experimental data on the possible interaction of doxycycline with mineral water and soft drinks are absent.
Aim. To study the possible interaction of doxycycline with salts of alkaline earth metals and its effect on bioavailability in the experiment in vitro.
Materials and methods. The study objects were doxycycline hyclate capsules, mineral waters and soft drinks. During the study a Mettler Toledo AB-204 / A analytical balance was used. The test “Dissolution” for solid dosage forms was performed on a PharmaTest-DT70 device (Germany). The quantitative content of the active substance was determined on a “Specord 200” spectrophotometer (Germany).
Results. There was an increase in the concentration of doxycycline in the medium of 0.1 M HCl solution when adding such mineral waters as “Karpatska Dzherelna”, “Truskavetska”, “Essentuki No. 17”, “Polyana kvasova”. With addition of “Sprite” soft drink a decrease in the concentration compared to the control sample was observed. The dissolution profile of doxycycline capsules in the medium of 0.1 M HCl with addition of “Truskavetska” mineral water is not comparable to the control sample. The dissolution profiles of other mineral waters studied and “Sprite” are similar.
Conclusions. The assumption can be made about the possible interaction of calcium and magnesium cations in waters mentioned above with the doxycycline hyclate molecule. In practical terms, this means unacceptability of simultaneous intake the mineral waters studied with doxycycline hyclate capsules.
References
Belousov, Yu. B., Gurevich, K. G. (2002). Farmateka, 6. Available at: http://www.pharmateca.ru/cgibin/statyi.pl?sid=527&
mid=1085056555&magid=44&full=1
Heorhiiants, V. А., Holovchenko, O. S., Dobrova, A. O., Materiienko, A. S.,Hubar, S. M., Tkachenko, O. V. (2017). Upravlinnia
yakistiu v farmatsii. Kharkiv : NUPh, 38.
Мyhal, А. V., Holovchenko, O. S., Georgiiants, V. А. (2015). Аnalitychna khimiia u farmastii. Kharkiv: NUPh, 75–76.
Mozayani, А., Raymon, L. (2012). Handbook of Drug Interactions: A Clinical and Forensic Guide, 2nd edition. NY.: Humana
Press, 827.
Коzlov, R. S., Pertseva, T. O., Dmytrychenko, V. V., Simonov, S. S. (2011). Ukrainskyi medychyi chasopys, 6 (86), 59–62.
Коzlov, R. S., Holub, A. V. Remedium. Available at: http://www.remedium.ru/doctor/gynaecology/detail.php?ID=67549
Feshchenko, Yu. I., Holubovska, O. A., Honcharov, K. A. et al. (2013). Ukrainskyi pulmonolohichnyi zhurnal, 1, 5–21.
Sapadin, A. N., Fleischmajer, R. (2006). Tetracyclines: Nonantibiotic properties and their clinical implications. Journal of the
American Academy of Dermatology, 54 (2), 258–265. doi: 10.1016/j.jaad.2005.10.004
Zupanets, І. А., Тkachenko, K. M., Оtrishko, I. A., Hrintsov, Ye. F. (2014). Ukrainskyi zhurnal klinichnoi ta laboratornoi medytsyny,
(3), 37–40.
Tkachenko, K. M., Zupanets, I. A., Shebeko, S. K., Otrishko, I. A., Grintsov, Ye. F. (2015). The Comparative Study of the Acute
Toxicity of Tetracyclines. The Pharma Innovation Journal, 4 (2), 59–62.
Lytvynenko, Ye. Yu., Myhal A. V., Holovchenko O. S., Heorhiiants V. A. (2017). Sposib kilkisnoho vyznachennia famotydynu,
kaltsiiu karbonatu ta mahniiu hidroksydu u suspenzii aptechnoho vyrobnytstva. Pat. 118408 Ukrainy MPK G01N 33/15,
G01N 31/22, G01J 3/00. № U 2017 01044; declared 06.02.2017; published 10.08.2017, № 15.
Bezuhlyi, P. O., Heorhiiants, V. A., Hrytsenko, I. S. (2013). Farmatsevtychnyi analiz. Kharkiv: NUPh; Zoloti storinky, 552.
United States Pharmacopeia 39. (2016). USP Convention Inc. Rockville. Available at: www.uspnf.com/uspnf/pub/index?usp=3
&nf=34&s=2&officialOn=December %201, %2202016
Nazarova, O. S., Bobrytska, L. O. (2012). Ekonomika ta zabezpechennia yakosti v farmatsii, 4 (24), 13–18.
Provedennia porivnialnykh doslidzhen in vitro dlia pidtverdzhennia ekvivalentnosti likarskykh zasobiv u tverdii dozovanii
formi systemnoi dii. Kyiv: Morion, 41.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
